These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 26541299

  • 1. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.
    Zhang P, Xu Y, Zhu X, Huang Y.
    Int J Pharm; 2015 Dec 30; 496(2):993-1005. PubMed ID: 26541299
    [Abstract] [Full Text] [Related]

  • 2. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y.
    Biomaterials; 2012 Feb 30; 33(5):1573-82. PubMed ID: 22093292
    [Abstract] [Full Text] [Related]

  • 3. A novel ligand conjugated nanoparticles for oral insulin delivery.
    Liu C, Shan W, Liu M, Zhu X, Xu J, Xu Y, Huang Y.
    Drug Deliv; 2016 Jul 30; 23(6):2015-25. PubMed ID: 26203690
    [Abstract] [Full Text] [Related]

  • 4. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M, Zhang J, Zhu X, Shan W, Li L, Zhong J, Zhang Z, Huang Y.
    J Control Release; 2016 Jan 28; 222():67-77. PubMed ID: 26686663
    [Abstract] [Full Text] [Related]

  • 5. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]

  • 6. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W, Zhu X, Liu M, Li L, Zhong J, Sun W, Zhang Z, Huang Y.
    ACS Nano; 2015 Mar 24; 9(3):2345-56. PubMed ID: 25658958
    [Abstract] [Full Text] [Related]

  • 7. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z, Guo H, Zhu X, Jin Y, Huang Y.
    J Pharm Pharm Sci; 2015 Mar 24; 18(2):155-70. PubMed ID: 26158281
    [Abstract] [Full Text] [Related]

  • 8. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
    Chen G, Svirskis D, Lu W, Ying M, Huang Y, Wen J.
    J Control Release; 2018 May 10; 277():142-153. PubMed ID: 29548985
    [Abstract] [Full Text] [Related]

  • 9. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB, Sarmento B, Carvalho RA, Neufeld RJ, Veiga F.
    Int J Pharm; 2011 Jun 30; 412(1-2):123-31. PubMed ID: 21501675
    [Abstract] [Full Text] [Related]

  • 10. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X, Guo S, Zhu C, Zhu Q, Gan Y, Rantanen J, Rahbek UL, Hovgaard L, Yang M.
    Biomaterials; 2013 Dec 30; 34(37):9678-87. PubMed ID: 24016855
    [Abstract] [Full Text] [Related]

  • 11. Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles.
    Zhang J, Zhu X, Jin Y, Shan W, Huang Y.
    Mol Pharm; 2014 May 05; 11(5):1520-32. PubMed ID: 24673570
    [Abstract] [Full Text] [Related]

  • 12. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F, Zhang M, Gao Y, Zhu S, Chen S, Liu W, Zhong H, Liu J.
    Drug Deliv; 2016 Jul 05; 23(6):2003-14. PubMed ID: 26181840
    [Abstract] [Full Text] [Related]

  • 13. Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin.
    Chen J, Liu C, Shan W, Xiao Z, Guo H, Huang Y.
    J Microencapsul; 2015 Jul 05; 32(7):632-41. PubMed ID: 26401551
    [Abstract] [Full Text] [Related]

  • 14. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R, Radmehr M, Dorkoosh FA, Ostad SN, Rafiee-Tehrani M.
    Drug Dev Ind Pharm; 2014 Dec 05; 40(12):1645-59. PubMed ID: 24093431
    [Abstract] [Full Text] [Related]

  • 15. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
    Tsai LC, Chen CH, Lin CW, Ho YC, Mi FL.
    Int J Biol Macromol; 2019 Apr 01; 126():141-150. PubMed ID: 30586591
    [Abstract] [Full Text] [Related]

  • 16. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
    Lopes M, Shrestha N, Correia A, Shahbazi MA, Sarmento B, Hirvonen J, Veiga F, Seiça R, Ribeiro A, Santos HA.
    J Control Release; 2016 Jun 28; 232():29-41. PubMed ID: 27074369
    [Abstract] [Full Text] [Related]

  • 17. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.
    Sandri G, Bonferoni MC, Rossi S, Ferrari F, Boselli C, Caramella C.
    AAPS PharmSciTech; 2010 Mar 28; 11(1):362-71. PubMed ID: 20232266
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.
    Li X, Wang C, Liang R, Sun F, Shi Y, Wang A, Liu W, Sun K, Li Y.
    Pharm Res; 2015 Mar 28; 32(3):1017-27. PubMed ID: 25270570
    [Abstract] [Full Text] [Related]

  • 20. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L, Ding J, He C, Cui L, Tang C, Yin C.
    Biomaterials; 2009 Oct 28; 30(29):5691-700. PubMed ID: 19615735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.